Midori Shima Selected Research

Midori Shima Research Topics

Disease

110	Hemophilia A (Haemophilia) 01/2024 - 03/2002
59	Hemorrhage 12/2023 - 03/2004
21	Thrombosis (Thrombus) 06/2023 - 06/2002
7	Hemophilia B (Haemophilia B) 01/2022 - 05/2008
7	Thrombotic Microangiopathies 03/2021 - 09/2016
5	Metrorrhagia (Spotting) 10/2023 - 01/2017
3	Pain (Aches) 11/2023 - 01/2007
3	Disease Progression 03/2023 - 01/2020
3	Type 3 von Willebrand Disease 09/2022 - 03/2006
3	Type 2 von Willebrand Disease 03/2021 - 03/2020
3	Myocardial Infarction 01/2021 - 09/2010
3	Disseminated Intravascular Coagulation 09/2020 - 06/2018
3	Joint Diseases (Joint Disease) 01/2019 - 06/2011
3	Body Weight (Weight, Body) 01/2018 - 11/2009
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2016 - 05/2008
3	Venous Thrombosis (Deep-Vein Thrombosis) 07/2013 - 05/2010
2	Inflammation (Inflammations) 12/2023 - 07/2019
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 09/2023 - 01/2020
2	Thrombasthenia (Glanzmann Thrombasthenia) 06/2023 - 02/2021
2	Infections 03/2023 - 11/2014
2	Human Influenza (Influenza) 01/2023 - 09/2016
2	Sepsis (Septicemia) 09/2020 - 02/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 07/2014
2	Thromboembolism 01/2020 - 01/2019
2	Purpura 06/2019 - 12/2013
2	von Willebrand Diseases (von Willebrand's Disease) 05/2019 - 02/2015
2	Neoplasms (Cancer) 06/2018 - 01/2017
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2017 - 01/2017
2	Thrombophilia 01/2017 - 06/2013
2	Hyperplasia 11/2009 - 12/2008
1	Lung Injury 12/2023
1	Factor VII Deficiency (Hypoproconvertinemia) 06/2023
1	Musculoskeletal Abnormalities 06/2023
1	Infectious Mononucleosis (Glandular Fever) 03/2023
1	Communicable Diseases (Infectious Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

59	Factor VIII (Coagulation Factor VIII)IBA 12/2023 - 03/2002
42	emicizumabIBA 01/2024 - 11/2014
20	Hemostatics (Antihemorrhagics)IBA 06/2023 - 01/2004
16	von Willebrand FactorIBA 12/2023 - 03/2004
13	Thrombin FDA Link 02/2022 - 10/2009
11	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 05/2008
11	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 01/2007
10	FibrinIBA 03/2021 - 10/2009
9	AntibodiesIBA 09/2022 - 03/2004
8	Thromboplastin (Tissue Factor)IBA 02/2021 - 10/2009
7	AutoantibodiesIBA 01/2020 - 02/2006
6	recombinant FVIIa (rFVIIa)FDA Link 06/2023 - 01/2004
6	AnticoagulantsIBA 01/2023 - 06/2013
6	prothrombin complex concentrates (PPSB)IBA 03/2021 - 01/2007
6	Prothrombin (Factor II)IBA 01/2021 - 04/2009
5	CoagulantsIBA 03/2023 - 01/2020
5	Fibrinolysin FDA Link 02/2022 - 07/2017
5	Monoclonal AntibodiesIBA 01/2021 - 10/2017
4	Neutralizing AntibodiesIBA 11/2023 - 06/2013
4	Immunoglobulin G (IgG)IBA 09/2022 - 03/2004
4	Factor IXa (Coagulation Factor IXa)IBA 01/2020 - 11/2014
4	AntigensIBA 07/2019 - 08/2003
3	Heme (Haem)IBA 09/2021 - 01/2019
3	Factor VIIIaIBA 03/2021 - 01/2017
3	Dacarbazine (DIC)FDA LinkGeneric 09/2020 - 06/2018
3	Factor X (Stuart Factor)IBA 01/2020 - 06/2013
3	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2003
3	Ellagic AcidIBA 01/2020 - 12/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2012
3	Protein CIBA 10/2018 - 06/2013
3	Therapeutic UsesIBA 01/2018 - 07/2008
3	Protein SIBA 01/2017 - 06/2013
3	IsoantibodiesIBA 05/2016 - 02/2006
2	fitusiranIBA 01/2023 - 01/2019
2	Bispecific AntibodiesIBA 01/2022 - 05/2020
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 06/2021 - 04/2013
2	CollagenIBA 02/2021 - 03/2020
2	Asparaginase (Elspar)FDA Link 01/2020 - 01/2017
2	AntithrombinsIBA 01/2017 - 06/2013
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2014 - 10/2009
2	Factor V (Coagulation Factor V)IBA 12/2013 - 01/2011
2	argatroban (MPQA)FDA Link 07/2013 - 10/2009
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 07/2013 - 05/2010
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2012 - 05/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011 - 08/2003
2	Benzene (Benzole)IBA 11/2009 - 12/2008
2	Ethanol (Ethyl Alcohol)IBA 10/2009 - 09/2006
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	LipopolysaccharidesIBA 12/2023
1	Factor VII (Proconvertin)IBA 06/2023
1	COVID-19 VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	concizumabIBA 01/2023
1	marstacimabIBA 01/2023

Therapy/Procedure

42	Therapeutics 11/2023 - 08/2003
5	Transplantation 03/2021 - 05/2005
5	Injections 05/2019 - 10/2012
2	Operative Surgical Procedures 10/2023 - 06/2023
2	Arthrodesis 08/2018 - 06/2011
2	Central Venous Catheters 01/2017 - 09/2016
2	Intravenous Infusions 05/2016 - 06/2015
2	Ligation 02/2016 - 05/2010
2	Tooth Extraction (Tooth Extractions) 12/2015 - 03/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2023
1	Platelet Transfusion (Blood Platelet Transfusions) 06/2023